The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
Completed · Phase 2 · Has a placebo group
Conditions studied: Treatment, Placebo
In brief
The goal of this study is to determine whether a study medication (d-cycloserine) improves the ability of older adults to perform on tests of neuropsychological functioning. Tests of neuropsychological functioning assess attention, memory, and executive functioning skills (for example, problem-solving, planning and organizing skills). It was hypothesized that participants who received study medication would perform better on neuropsychological tests than would participants who received the sugar pill.
Key facts
- Study ID
- NCT01361633
- Run by
- Hartford Hospital
- People needed
- 51
- Starts
- 2008-01-01
- Expected to finish
- 2009-02-01
- Last updated by the study team
- 2021-02-18
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- age 60 or older
- native English speaker
You may not qualify if…
- diagnosis of current psychiatric disorder
- substance abuse past 3 months
- cognitive impairment
- neurological disorder
- poor health or unstable medical condition
- positive toxicology screen
- current use of isoniazid
- current use of trecator
- severe renal insufficiency
Where it is running
- Anxiety Disorders Center, Institute of Living/Hartford Hospital — Hartford, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.